Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00870818 · ClinicalTrials.gov registry record · NA
Protege Extension Trial - Long Term Follow Up Trial for Subjects Who Completed the Protege Study (CP-MGA031-01)
A NA study, sponsored by MacroGenics.
- Terminated
- Registry status
- NA
- Development phase
- 219
- Enrollment target
NCT00870818 is a NA study that was terminated before completion, run by MacroGenics. The registered enrollment target is 219 participants.
The verdict
NCT00870818, a NA study, was terminated before completion, sponsored by MacroGenics.
- TERMINATED
- Registry status
- NA
- Development phase
- 219 participants
- Enrollment target
Study Summary
The purpose of this study is to assess the long term safety and efficacy in subjects with Type 1 Diabetes Mellitus who completed the Protege Study (CP-MGA031-01).
Interventions
- DIAGNOSTIC_TEST Blood samples for safety
- BEHAVIORAL Patient reported outcome questionnaires
- DIAGNOSTIC_TEST Analysis of T-cell subsets
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 219 participants |
| Start Date | 2009-02 |
| Est. Completion | 2011-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00870818
The ClinicalTrials.gov registry entry for NCT00870818 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 219 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is MacroGenics, which has 36 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Blood samples for safety is the first listed.
NCT00870818 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00870818 about?
NCT00870818 is a clinical study titled "Protege Extension Trial - Long Term Follow Up Trial for Subjects Who Completed the Protege Study (CP-MGA031-01)". The purpose of this study is to assess the long term safety and efficacy in subjects with Type 1 Diabetes Mellitus who completed the Protege Study (CP-MGA031-01).
What is the current status of trial NCT00870818?
This trial is currently terminated. It is a NA study. The enrollment target is 219 participants. The study started on 2009-02. Estimated completion is 2011-05.
What interventions are being tested in trial NCT00870818?
The interventions under investigation include: Blood samples for safety (DIAGNOSTIC_TEST), Patient reported outcome questionnaires (BEHAVIORAL), Analysis of T-cell subsets (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT00870818?
This trial is sponsored by MacroGenics, which has 36 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.